Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 623 entries
Sorted by: Best Match Show Resources per page
Community providers' experiences with evidence-based practices: The role of therapist race/ethnicity

Minority STEM training

Brookman-Frazee L, Kodish T, Ramos G.
GSID: qb7RPjjSE5oJ
G Ramos, L Brookman-Frazee, T Kodish… - … and Ethnic Minority …, 2021 - psycnet.apa.org

… mental health workforce. This study shows that racial/ethnic … The following main topics were covered using the stem … Training school mental health providers to deliver cognitive-…

Cite
Ramos, G., Brookman-Frazee, L., Kodish, T., Rodriguez, A., & Lau, A. S. (2021). Community providers’ experiences with evidence-based practices: The role of therapist race/ethnicity. Cultural Diversity and Ethnic Minority Psychology, 27(3), 471.
Ramos, Giovanni, et al. "Community providers’ experiences with evidence-based practices: The role of therapist race/ethnicity." Cultural Diversity and Ethnic Minority Psychology 27.3 (2021): 471.
Copy Download .nbib Format: MLA
Faba bean hulls as a potential source of pectin.

Journal of food science and technology

Korish M.
PMID: 26345029
J Food Sci Technol. 2015 Sep;52(9):6061-6. doi: 10.1007/s13197-014-1688-9. Epub 2014 Dec 20.

This study aimed for the first time to assess the potential use of faba bean hulls as a source of pectin. The study involved extracting pectin under various conditions of pH, temperature and extraction time and determining how these...

Cite
Korish M. Faba bean hulls as a potential source of pectin. J Food Sci Technol. 2014;52(9):6061-6doi: 10.1007/s13197-014-1688-9.
Korish, M. (2015). Faba bean hulls as a potential source of pectin. Journal of food science and technology, 52(9), 6061-6. https://doi.org/10.1007/s13197-014-1688-9
Korish, Mohamed. "Faba bean hulls as a potential source of pectin." Journal of food science and technology vol. 52,9 (2015): 6061-6. doi: https://doi.org/10.1007/s13197-014-1688-9
Korish M. Faba bean hulls as a potential source of pectin. J Food Sci Technol. 2015 Sep;52(9):6061-6. doi: 10.1007/s13197-014-1688-9. Epub 2014 Dec 20. PMID: 26345029; PMCID: PMC4554626.
Copy Download .nbib Format: NLM
Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register.

NPJ schizophrenia

Cardinal RN, Savulich G, Mann LM, Fernández-Egea E.
PMID: 27336041
NPJ Schizophr. 2015 Oct 21;1:15035. doi: 10.1038/npjschz.2015.35. eCollection 2015.

BACKGROUND: The impact of psychotropic drug choice upon admissions for schizophrenia is not well understood.AIMS: To examine the association between antipsychotic/antidepressant use and time in hospital for patients with schizophrenia.METHODS: We conducted an observational study, using 8 years' admission...

Cite
Cardinal RN, Savulich G, Mann LM, et al. Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ Schizophr. 2015;1:15035doi: 10.1038/npjschz.2015.35.
Cardinal, R. N., Savulich, G., Mann, L. M., & Fernández-Egea, E. (2015). Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ schizophrenia, 115035. https://doi.org/10.1038/npjschz.2015.35
Cardinal, Rudolf N, et al. "Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register." NPJ schizophrenia vol. 1 (2015): 15035. doi: https://doi.org/10.1038/npjschz.2015.35
Cardinal RN, Savulich G, Mann LM, Fernández-Egea E. Association between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case register. NPJ Schizophr. 2015 Oct 21;1:15035. doi: 10.1038/npjschz.2015.35. eCollection 2015. PMID: 27336041; PMCID: PMC4849458.
Copy Download .nbib Format: NLM
Screening for GPR101 defects in pediatric pituitary corticotropinomas.

Endocrine-related cancer

Trivellin G, Correa RR, Batsis M, Faucz FR, Chittiboina P, Bjelobaba I, Larco DO, Quezado M, Daly AF, Stojilkovic SS, Wu TJ, Beckers A, Lodish M, Stratakis CA.
PMID: 26962002
Endocr Relat Cancer. 2016 Jun 01;23(5):357-365. doi: 10.1530/ERC-16-0091.

Cushing disease (CD) in children is caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas. Germline or somatic mutations in genes such as MEN1, CDKIs, AIP, and USP8 have been identified in pediatric CD, but the genetic defects in a significant...

Cite
Trivellin G, Correa RR, Batsis M, et al. Screening for GPR101 defects in pediatric pituitary corticotropinomas. Endocr Relat Cancer. 2016;23(5):357-365doi: 10.1530/ERC-16-0091.
Trivellin, G., Correa, R. R., Batsis, M., Faucz, F. R., Chittiboina, P., Bjelobaba, I., Larco, D. O., Quezado, M., Daly, A. F., Stojilkovic, S. S., Wu, T. J., Beckers, A., Lodish, M., & Stratakis, C. A. (2016). Screening for GPR101 defects in pediatric pituitary corticotropinomas. Endocrine-related cancer, 23(5), 357-365. https://doi.org/10.1530/ERC-16-0091
Trivellin, Giampaolo, et al. "Screening for GPR101 defects in pediatric pituitary corticotropinomas." Endocrine-related cancer vol. 23,5 (2016): 357-365. doi: https://doi.org/10.1530/ERC-16-0091
Trivellin G, Correa RR, Batsis M, Faucz FR, Chittiboina P, Bjelobaba I, Larco DO, Quezado M, Daly AF, Stojilkovic SS, Wu TJ, Beckers A, Lodish M, Stratakis CA. Screening for GPR101 defects in pediatric pituitary corticotropinomas. Endocr Relat Cancer. 2016 Jun 01;23(5):357-365. doi: 10.1530/ERC-16-0091. PMID: 26962002; PMCID: PMC5017905.
Copy Download .nbib Format: NLM
Mental health and human trafficking: responding to survivors' needs.

BJPsych international

Altun S, Abas M, Zimmerman C, Howard LM, Oram S.
PMID: 29093930
BJPsych Int. 2017 Feb 01;14(1):21-23. doi: 10.1192/s205647400000163x. eCollection 2017 Feb.

Mental health professionals have opportunities to intervene and provide care for trafficked people. Research shows that mental health problems - including depression, anxiety and post-traumatic stress disorder - are prevalent among trafficked people, and that at least some trafficked...

Cite
Altun S, Abas M, Zimmerman C, et al. Mental health and human trafficking: responding to survivors' needs. BJPsych Int. 2017;14(1):21-23doi: 10.1192/s205647400000163x.
Altun, S., Abas, M., Zimmerman, C., Howard, L. M., & Oram, S. (2017). Mental health and human trafficking: responding to survivors' needs. BJPsych international, 14(1), 21-23. https://doi.org/10.1192/s205647400000163x
Altun, Sukran, et al. "Mental health and human trafficking: responding to survivors' needs." BJPsych international vol. 14,1 (2017): 21-23. doi: https://doi.org/10.1192/s205647400000163x
Altun S, Abas M, Zimmerman C, Howard LM, Oram S. Mental health and human trafficking: responding to survivors' needs. BJPsych Int. 2017 Feb 01;14(1):21-23. doi: 10.1192/s205647400000163x. eCollection 2017 Feb. PMID: 29093930; PMCID: PMC5618827.
Copy Download .nbib Format: NLM
Female sexual dysfunction: a focus on flibanserin.

International journal of women's health

Lodise NM.
PMID: 29066935
Int J Womens Health. 2017 Oct 11;9:757-767. doi: 10.2147/IJWH.S83747. eCollection 2017.

Flibanserin is the first US Food and Drug Administration (FDA)-approved option for sexual dysfunction, specifically low sexual desire. Until recently, there were no FDA-approved medication options to assist the ~40% of women affected by female sexual dysfunction (FSD). Often,...

Cite
Lodise NM. Female sexual dysfunction: a focus on flibanserin. Int J Womens Health. 2017;9:757-767doi: 10.2147/IJWH.S83747.
Lodise, N. M. (2017). Female sexual dysfunction: a focus on flibanserin. International journal of women's health, 9757-767. https://doi.org/10.2147/IJWH.S83747
Lodise, Nicole M. "Female sexual dysfunction: a focus on flibanserin." International journal of women's health vol. 9 (2017): 757-767. doi: https://doi.org/10.2147/IJWH.S83747
Lodise NM. Female sexual dysfunction: a focus on flibanserin. Int J Womens Health. 2017 Oct 11;9:757-767. doi: 10.2147/IJWH.S83747. eCollection 2017. PMID: 29066935; PMCID: PMC5644557.
Copy Download .nbib Format: NLM
Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.

Canadian journal of kidney health and disease

Ward DR, Moist LM, MacRae JM, Scott-Douglas N, Zhang J, Tonelli M, Lok CE, Soroka SD, Hemmelgarn BR.
PMID: 25960883
Can J Kidney Health Dis. 2014 Jul 08;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014.

BACKGROUND: We previously reported a reduction in central venous catheter (CVC) malfunction when using once-weekly recombinant tissue-plasminogen activator (rt-PA) as a locking solution, compared with thrice-weekly heparin.OBJECTIVES: To identify risk factors for CVC malfunction to inform a targeted strategy...

Cite
Ward DR, Moist LM, MacRae JM, et al. Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial. Can J Kidney Health Dis. 2014;1:15doi: 10.1186/2054-3581-1-15.
Ward, D. R., Moist, L. M., MacRae, J. M., Scott-Douglas, N., Zhang, J., Tonelli, M., Lok, C. E., Soroka, S. D., & Hemmelgarn, B. R. (2014). Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial. Canadian journal of kidney health and disease, 115. https://doi.org/10.1186/2054-3581-1-15
Ward, David R, et al. "Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial." Canadian journal of kidney health and disease vol. 1 (2014): 15. doi: https://doi.org/10.1186/2054-3581-1-15
Ward DR, Moist LM, MacRae JM, Scott-Douglas N, Zhang J, Tonelli M, Lok CE, Soroka SD, Hemmelgarn BR. Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial. Can J Kidney Health Dis. 2014 Jul 08;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014. PMID: 25960883; PMCID: PMC4424538.
Copy Download .nbib Format: NLM
What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study.

BMJ open

Lilford RJ, Bentham LM, Armstrong MJ, Neuberger J, Girling AJ.
PMID: 23794594
BMJ Open. 2013 Jun 20;3(6). doi: 10.1136/bmjopen-2013-003099.

OBJECTIVE: Evaluation of predictive value of liver function tests (LFTs) for the detection of liver-related disease in primary care.DESIGN: A prospective observational study.SETTING: 11 UK primary care practices.PARTICIPANTS: Patients (n=1290) with an abnormal eight-panel LFT (but no previously diagnosed...

Cite
Lilford RJ, Bentham LM, Armstrong MJ, et al. What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study. BMJ Open. 2013;3(6)doi: 10.1136/bmjopen-2013-003099.
Lilford, R. J., Bentham, L. M., Armstrong, M. J., Neuberger, J., & Girling, A. J. (2013). What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study. BMJ open, 3(6), . https://doi.org/10.1136/bmjopen-2013-003099
Lilford, Richard J, et al. "What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study." BMJ open vol. 3,6 (2013). doi: https://doi.org/10.1136/bmjopen-2013-003099
Lilford RJ, Bentham LM, Armstrong MJ, Neuberger J, Girling AJ. What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study. BMJ Open. 2013 Jun 20;3(6). doi: 10.1136/bmjopen-2013-003099. PMID: 23794594; PMCID: PMC3686167.
Copy Download .nbib Format: NLM
Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells.

Advances in pharmacological sciences

Krisnamurti DG, Louisa M, Anggraeni E, Wanandi SI.
PMID: 26981116
Adv Pharmacol Sci. 2016;2016:6702424. doi: 10.1155/2016/6702424. Epub 2016 Feb 14.

Tamoxifen is the first line drug used in the treatment of estrogen receptor-positive (ER+) breast cancer. The development of multidrug resistance (MDR) to tamoxifen remains a major challenge in the treatment of cancer. One of the mechanisms related to...

Cite
Krisnamurti DG, Louisa M, Anggraeni E, et al. Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells. Adv Pharmacol Sci. 2016;2016:6702424doi: 10.1155/2016/6702424.
Krisnamurti, D. G., Louisa, M., Anggraeni, E., & Wanandi, S. I. (2016). Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells. Advances in pharmacological sciences, 20166702424. https://doi.org/10.1155/2016/6702424
Krisnamurti, Desak Gede Budi, et al. "Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells." Advances in pharmacological sciences vol. 2016 (2016): 6702424. doi: https://doi.org/10.1155/2016/6702424
Krisnamurti DG, Louisa M, Anggraeni E, Wanandi SI. Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells. Adv Pharmacol Sci. 2016;2016:6702424. doi: 10.1155/2016/6702424. Epub 2016 Feb 14. PMID: 26981116; PMCID: PMC4769734.
Copy Download .nbib Format: NLM
A Cincinnati Special Class.

The Psychological clinic

Doll LM.
PMID: 28909438
Psychol Clin. 1909 Apr 15;3(2):34-44.

No abstract available.

Cite
Doll LM. A Cincinnati Special Class. Psychol Clin. 1909;3(2):34-44
Doll, L. M. (1909). A Cincinnati Special Class. The Psychological clinic, 3(2), 34-44.
Doll, Louise M. "A Cincinnati Special Class." The Psychological clinic vol. 3,2 (1909): 34-44.
Doll LM. A Cincinnati Special Class. Psychol Clin. 1909 Apr 15;3(2):34-44. PMID: 28909438; PMCID: PMC5138965.
Copy Download .nbib Format: NLM
An assessment of botanical air purification as a formaldehyde mitigation measure under dynamic laboratory chamber conditions.

Environmental pollution (Barking, Essex : 1987)

Godish T, Guindon C.
PMID: 15092351
Environ Pollut. 1989;62(1):13-20. doi: 10.1016/0269-7491(89)90092-4.

This study was designed to determine the effectiveness of spider plants (Clorophytum elatum var. vittatium) as a botanical air purification measure for formaldehyde under dynamic laboratory chamber conditions. Significant reductions in chamber formaldehyde levels were observed when spider plants...

Cite
Godish T, Guindon C. An assessment of botanical air purification as a formaldehyde mitigation measure under dynamic laboratory chamber conditions. Environ Pollut. 1989;62(1):13-20doi: 10.1016/0269-7491(89)90092-4.
Godish, T., & Guindon, C. (1989). An assessment of botanical air purification as a formaldehyde mitigation measure under dynamic laboratory chamber conditions. Environmental pollution (Barking, Essex : 1987), 62(1), 13-20. https://doi.org/10.1016/0269-7491(89)90092-4
Godish, T, and Guindon, C. "An assessment of botanical air purification as a formaldehyde mitigation measure under dynamic laboratory chamber conditions." Environmental pollution (Barking, Essex : 1987) vol. 62,1 (1989): 13-20. doi: https://doi.org/10.1016/0269-7491(89)90092-4
Godish T, Guindon C. An assessment of botanical air purification as a formaldehyde mitigation measure under dynamic laboratory chamber conditions. Environ Pollut. 1989;62(1):13-20. doi: 10.1016/0269-7491(89)90092-4. PMID: 15092351.
Copy Download .nbib Format: NLM
The estimation of three-phase invariants when anomalous scatterers are present: the limits.

Acta crystallographica. Section A, Foundations of crystallography

Giacovazzo C, Ladisa M, Siliqi D.
PMID: 14581756
Acta Crystallogr A. 2003 Nov;59:569-76. doi: 10.1107/s0108767303021329. Epub 2003 Nov 01.

The probabilistic formula provided by Hauptman and Giacovazzo for estimating three-phase invariants when anomalous scatterers are present is revisited. Its main defects are: (a) it is absolutely resistant to any attempt at interpreting it in terms of parameters accessible...

Cite
Giacovazzo C, Ladisa M, Siliqi D. The estimation of three-phase invariants when anomalous scatterers are present: the limits. Acta Crystallogr A. 2003;59:569-76doi: 10.1107/s0108767303021329.
Giacovazzo, C., Ladisa, M., & Siliqi, D. (2003). The estimation of three-phase invariants when anomalous scatterers are present: the limits. Acta crystallographica. Section A, Foundations of crystallography, 59569-76. https://doi.org/10.1107/s0108767303021329
Giacovazzo, Carmelo, et al. "The estimation of three-phase invariants when anomalous scatterers are present: the limits." Acta crystallographica. Section A, Foundations of crystallography vol. 59 (2003): 569-76. doi: https://doi.org/10.1107/s0108767303021329
Giacovazzo C, Ladisa M, Siliqi D. The estimation of three-phase invariants when anomalous scatterers are present: the limits. Acta Crystallogr A. 2003 Nov;59:569-76. doi: 10.1107/s0108767303021329. Epub 2003 Nov 01. PMID: 14581756.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 623 entries